Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis.
about
Systemic antibiotic therapy for chronic osteomyelitis in adultsEvaluation of quinolones in experimental animal models of infections.Role of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin.Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus.Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis.Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.Efficacy of sparfloxacin and autoradiographic diffusion pattern of [14C]Sparfloxacin in experimental Staphylococcus aureus joint prosthesis infection.In vitro activities of ciprofloxacin and rifampin alone and in combination against growing and nongrowing strains of methicillin-susceptible and methicillin-resistant Staphylococcus aureus.Efficacy of linezolid plus rifampin in an experimental model of methicillin-susceptible Staphylococcus aureus endocarditis.Synergistic activity of ceftobiprole and vancomycin in a rat model of infective endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.Susceptibility of Staphylococcus aureus growing on fibronectin-coated surfaces to bactericidal antibiotics.Influence of rifampin on fleroxacin pharmacokinetics.Local Intramedullary Delivery of Vancomycin Can Prevent the Development of Long Bone Staphylococcus aureus Infection.Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.Efficacies of various antimicrobial agents in treatment of Staphylococcus aureus abscesses and correlation with in vitro tests of antimicrobial activity and neutrophil killingCrossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin alone and in combination in healthy elderly volunteers.Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations.Pharmacodynamics of antibiotics to treat multidrug-resistant Gram-positive hospital infections.Antimicrobial therapy for bone and joint infections.Rifampin combination therapy for nonmycobacterial infections.Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin.Quinolone resistance in Pseudomonas aeruginosa and Staphylococcus aureus. Development during therapy and clinical significance.Osteomyelitis management: More art than science?Antagonistic effect of rifampin on the efficacy of high-dose levofloxacin in staphylococcal experimental foreign-body infectionTreatment with linezolid or vancomycin in combination with rifampin is effective in an animal model of methicillin-resistant Staphylococcus aureus foreign body osteomyelitis.Toxic effect of rifampicin on human osteoblast-like cells.Staphylococcus epidermidis is cleared from biomaterial implants but persists in peri-implant tissue in mice despite rifampicin/vancomycin treatment.
P2860
Q28714211-BE4F975F-8D85-4C4C-AFA0-BBA8EA7590D2Q30446615-A9373316-EF62-40BD-9411-C35F94BBF8DFQ33750776-5D502846-A9E0-4576-B534-9327D07C921DQ34107094-45176F55-5E16-4036-81A5-EA15EC00A9F4Q34885043-E65E7532-73CC-444D-BD11-3EB8B9E64AC0Q35116767-8A53E1DC-8AA2-4CA6-8101-F496175E2263Q35126785-7ED7EA23-871F-4E8F-8757-410EAF2EBBFFQ35136601-76573F81-4C62-41F0-ADCD-9BAD31CD59ECQ35165783-9E16B3C9-531C-4AFF-91C2-0CE6B78A50EEQ35806369-9115F9FD-ABBB-456E-959B-93464E839889Q35810889-B366B324-F750-4D14-AB15-59C2B75580F2Q35897356-DEE459B3-9415-4ADF-A416-91F3244FF096Q36089510-2E92109B-D736-4323-ACCB-B1C74A676F81Q36409465-651A3BA7-F65B-496A-AF48-A2E70727D630Q36757117-7AC99C13-5F38-49CD-9A9E-E3E30A0F1C03Q36757133-FD3FC5CC-6A95-44EC-A333-BBF1B4FF09D6Q36757553-D7650893-65A6-4A4F-995A-6EB759C6BB8AQ36777850-E2DB622E-5AD8-4C72-860F-574F89B38C4EQ37354361-F42512C9-3952-4590-B25E-EFF941283C14Q37672039-5DD68D02-C635-44A9-92A9-F264CAD10AC1Q40088846-3B74AB2C-4BCA-49AC-B315-E8158EA790D9Q40633555-9C079B26-9338-4251-AA6F-65086ACE1AAEQ41891608-4C279BE6-B1E1-4AAD-BD95-C0A28E97F0ABQ41913615-40867911-2BC5-46E6-A194-6C95E7782109Q42706257-D6081A98-AF15-49DD-B379-AC0026CB67CCQ43741115-994D724E-DC1C-4A5B-8151-A661B372C8FCQ45216560-1D221E30-F5D1-406B-AA35-3866AB19E4D0
P2860
Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Comparative efficacies of cipr ...... aureus chronic osteomyelitis.
@en
Comparative efficacies of cipr ...... aureus chronic osteomyelitis.
@nl
type
label
Comparative efficacies of cipr ...... aureus chronic osteomyelitis.
@en
Comparative efficacies of cipr ...... aureus chronic osteomyelitis.
@nl
prefLabel
Comparative efficacies of cipr ...... aureus chronic osteomyelitis.
@en
Comparative efficacies of cipr ...... aureus chronic osteomyelitis.
@nl
P2093
P2860
P356
P1476
Comparative efficacies of cipr ...... aureus chronic osteomyelitis.
@en
P2093
P2860
P304
P356
10.1128/AAC.34.6.1014
P407
P577
1990-06-01T00:00:00Z